Precision NanoSystems NanoAssemblr Ignite for nanomedicine development
Conventional nanoparticle manufacturing methods can be sensitive to reaction conditions, difficult to reproduce, labour intensive and challenging to scale. NanoAssemblr Ignite solves these significant issues and allows scientists to create transformative medicines at the bench scale. It paves the way for new nanomedicine-based gene and cell therapies, as well as small molecule- and protein-based drugs to treat cancer, rare disease and infectious disease.
NanoAssemblr Ignite is designed to make preclinical laboratory-scale nanoparticle production efficient, reproducible and tuneable. Validated by over 100 peer-reviewed publications, the system is fast, simple and intuitive to operate. Nanomedicines are prepared in less than a minute, allowing rapid optimisation of particle properties.
NanoAssemblr technology takes advantage of the physics of fluids confined to channels about the width of a human hair and containing specially engineered microscopic features that control the conditions of nanoparticle formation. By controlling fluid flow in the microchannels, users can reproducibly control particle properties and manufacture high-quality drug products through a single mixer across scales.
NanoAssemblr Ignite enables rapid benchtop-scale development of nanoparticle-based RNA, DNA, CRISPR, small molecule and protein therapeutics. Optimised drug products are predictably scaled to advanced preclinical and clinical scale with the NxGen technology on the NanoAssemblr Blaze and GMP Systems.
For more information: https://www.atascientific.com.au/products/nanoassemblr-ignite/.
Phone: 02 9541 3500
CELLINK has launched the C.WASH — an innovative liquid handling system for media change in...
The modular, closed cell therapy processing system enables scalable cell therapy development and...
MP Biomedicals' FastPrep family is a suite of versatile homogenisers, interchangeable...